+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Allergy Rhinitis Drugs Market 2020-2024 - Product Image

Global Allergy Rhinitis Drugs Market 2020-2024

  • ID: 5007857
  • Report
  • March 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Alcon Inc.
  • ALK-Abello AS
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • MORE
Global Allergy Rhinitis Drugs Market 2020-2024

The publisher has been monitoring the global allergy rhinitis drugs market 2020-2024 and it is poised to grow by USD 2.4 bn during 2020-2024, progressing at a CAGR of 4% during the forecast period. The report on the global allergy rhinitis drugs market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergic rhinitis. In addition, increasing awareness about allergic rhinitis is anticipated to boost the growth of the global allergy rhinitis drugs market 2020-2024 as well.

Market Segmentation

Global allergy rhinitis drugs market 2020-2024 is segmented as below:

Product:
  • Antihistamines
  • Intranasal Corticosteroids
  • Immunotherapies
  • Others
Geographic Segmentation:
  • APAC
  • Europe
  • MEA
  • North America
  • South America
Key Trends for global allergy rhinitis drugs market 2020-2024 growth

This study identifies increasing awareness about allergic rhinitis as the prime reasons driving the global allergy rhinitis drugs market 2020-2024 growth during the next few years.

Prominent vendors in global allergy rhinitis drugs market 2020-2024

The publisher provides a detailed analysis of around 25 vendors operating in the global allergy rhinitis drugs market 2020-2024, including some of the vendors such as Alcon Inc., ALK-Abello AS, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi and Stallergenes Greer Ltd. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alcon Inc.
  • ALK-Abello AS
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product placement
  • Antihistamines - Market size and forecast 2019-2024
  • Intranasal corticosteroids - Market size and forecast 2019-2024
  • Immunotherapies - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Product
Customer landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
Drivers, Challenges, and Trends
  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Alcon Inc.
  • ALK-Abello AS
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Stallergenes Greer Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 5
5. Key Finding 6
6. Key Finding 7
7. Key Finding 8
8. Market in focus
10. Parent market
13. Market characteristics
15. Offerings of vendors included in the market definition
17. Market segments
22. Global - Market size and forecast 2019 - 2024 ($ million)
23. Global market: Year-over-year growth 2019 - 2024 (%)
24. Five forces analysis 2019 & 2024
25. Bargaining power of buyers
26. Bargaining power of suppliers
27. Threat of new entrants
28. Threat of substitutes
29. Threat of rivalry
30. Market condition - Five forces 2019
31. Product placement - Market share 2019-2024 (%)
32. Comparison by Product placement
33. Antihistamines - Market size and forecast 2019-2024 ($ million)
34. Antihistamines - Year-over-year growth 2019-2024 (%)
35. Intranasal corticosteroids - Market size and forecast 2019-2024 ($ million)
36. Intranasal corticosteroids - Year-over-year growth 2019-2024 (%)
37. Immunotherapies - Market size and forecast 2019-2024 ($ million)
38. Immunotherapies - Year-over-year growth 2019-2024 (%)
39. Others - Market size and forecast 2019-2024 ($ million)
40. Others - Year-over-year growth 2019-2024 (%)
41. Market opportunity by Product
42. Customer landscape
43. Market share by geography 2019-2024 (%)
44. Geographic comparison
45. North America - Market size and forecast 2019-2024 ($ million)
46. North America - Year-over-year growth 2019-2024 (%)
47. Europe - Market size and forecast 2019-2024 ($ million)
48. Europe - Year-over-year growth 2019-2024 (%)
49. APAC - Market size and forecast 2019-2024 ($ million)
50. APAC - Year-over-year growth 2019-2024 (%)
51. South America - Market size and forecast 2019-2024 ($ million)
52. South America - Year-over-year growth 2019-2024 (%)
53. MEA - Market size and forecast 2019-2024 ($ million)
54. MEA - Year-over-year growth 2019-2024 (%)
55. Key leading countries
56. Market opportunity by geography ($ million)
57. Impact of drivers and challenges
58. Vendor landscape
60. Landscape disruption
62. Industry risks
64. Vendors covered
66. Market positioning of vendors
67. Alcon Inc. - Overview
68. Alcon Inc. - Business segments
69. Alcon Inc. - Key offerings
70. Alcon Inc. - Key customers
71. Alcon Inc. - Segment focus
72. ALK-Abello AS - Overview
73. ALK-Abello AS - Product and service
74. ALK-Abello AS - Key offerings
75. ALK-Abello AS - Key customers
76. ALK-Abello AS - Segment focus
77. Dr. Reddy's Laboratories Ltd. - Overview
78. Dr. Reddy's Laboratories Ltd. - Business segments
79. Dr. Reddy's Laboratories Ltd. - Key offerings
80. Dr. Reddy's Laboratories Ltd. - Key customers
81. Dr. Reddy's Laboratories Ltd. - Segment focus
82. GlaxoSmithKline Plc - Overview
83. GlaxoSmithKline Plc - Business segments
84. GlaxoSmithKline Plc - Key offerings
85. GlaxoSmithKline Plc - Key customers
86. GlaxoSmithKline Plc - Segment focus
87. Glenmark Pharmaceuticals Ltd. - Overview
88. Glenmark Pharmaceuticals Ltd. - Product and service
89. Glenmark Pharmaceuticals Ltd. - Key offerings
90. Glenmark Pharmaceuticals Ltd. - Key customers
91. Glenmark Pharmaceuticals Ltd. - Segment focus
92. Merck & Co. Inc. - Overview
93. Merck & Co. Inc. - Business segments
94. Merck & Co. Inc. - Key offerings
95. Merck & Co. Inc. - Key customers
96. Merck & Co. Inc. - Segment focus
97. Novartis AG - Overview
98. Novartis AG - Business segments
99. Novartis AG - Key offerings
100. Novartis AG - Key customers
101. Novartis AG - Segment focus
102. Pfizer Inc. - Overview
103. Pfizer Inc. - Business segments
104. Pfizer Inc. - Key offerings
105. Pfizer Inc. - Key customers
106. Pfizer Inc. - Segment focus
107. Sanofi - Overview
108. Sanofi - Business segments
109. Sanofi - Key offerings
110. Sanofi - Key customers
111. Sanofi - Segment focus
112. Stallergenes Greer Ltd. - Overview
113. Stallergenes Greer Ltd. - Product and service
114. Stallergenes Greer Ltd. - Key offerings
115. Stallergenes Greer Ltd. - Key customers
116. Stallergenes Greer Ltd. - Segment focus
118. Currency conversion rates for US$
119. Research Methodology
120. Validation techniques employed for market sizing
121. Information sources
122. List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Alcon Inc.
  • ALK-Abello AS
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • MORE
The publisher recognizes the following companies as the key players in the global allergy rhinitis drugs market 2020-2024: Alcon Inc., ALK-Abello AS, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi and Stallergenes Greer Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the increasing awareness about allergic rhinitis."

According to the report, one of the major drivers for this market is the increasing prevalence of allergic rhinitis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Alcon Inc.
  • ALK-Abello AS
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd.
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Stallergenes Greer Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll